Article Name Predictive Diagnostics
Strategic move strengthens Clario’s leadership in medical imaging and bolsters expertise in multiple sclerosis and neurological drug development.
17th March, 2025
Strategic Agreement Brings Evidence-Based Clinical Pathways to Radiation Oncology Workflows, Improving Care Quality and Efficiency
14th March, 2025
The integrated clinical chemistry and immunoassay system enhances efficiency, streamlines lab workflows, and delivers accurate diagnostics in a compact design.
11th March, 2025
Largest head-to-head TAVR study highlights Evolut’s lower bioprosthetic valve dysfunction and improved durability in patients with small aortic annulus, reinforcing clinical decision-making in transcatheter valve therapy.
10th March, 2025
Court ruling dismisses claims against Co-Diagnostics, reinforcing the company’s commitment to transparency and innovation in molecular diagnostics.
07th March, 2025
Strategic agreement integrates Optellum’s AI-powered lung nodule analysis with Volpara’s early cancer detection tools, enabling a more comprehensive approach to patient risk evaluation.
05th March, 2025
The acquisition adds the ultrasound-based TIVUS™ system to Boston Scientific’s interventional portfolio, enhancing treatment options for hypertension and expanding its presence in renal denervation therapy.
04th March, 2025
Early glaucoma detection, SightScore™ empowers eye care professionals with advanced genetic insights to identify high-risk individuals before symptoms appear, paving the way for proactive vision care.
03rd March, 2025
Offering a long-acting, non-hormonal birth control option, the approval marks a significant milestone in expanding contraceptive choices for individuals seeking hormone-free alternatives.
03rd March, 2025
New AI-driven technology accelerates infection detection in peritoneal dialysis patients, enhances air quality monitoring, and optimizes laboratory analysis across industries.
03rd February, 2025
Collaboration brings clinical-grade magnetoencephalography (MEG) technology to consumers, launching first brain health center in London.
28th February, 2025
New microelectrothermoforming (μETF) method improves neural recording and stimulation, with applications in artificial retinas and brain-computer interfaces.
28th February, 2025
Six-month study demonstrates 85% symptom reduction and strong safety profile, advancing a minimally invasive solution for urgency urinary incontinence treatment.
27th February, 2025
The initiative enhances medical education by equipping healthcare professionals with advanced Microwave Ablation techniques to improve cancer treatment outcomes worldwide.
27th February, 2025
The initiative strengthens opioid prevention across Alabama by providing communities with vital education and at-home medication disposal solutions to reduce misuse and accidental overdoses.
27th February, 2025
The collaboration enhances Esco's IVF instrument portfolio with Allwin's consumables, offering a comprehensive solution for IVF clinicians and embryologists while expanding market presence in India.
26th February, 2025
Regulatory green light follows IMROZ Phase 3 study results showing significant progression-free survival benefit
25th February, 2025
The new 2 mL pre-filled pen option expands individualized treatment choices for hereditary angioedema (HAE) patients, reinforcing Takeda’s commitment to reducing disease burden and improving quality of life.
25th February, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer